Visual Summary: SMFM Consult Series #56: Hepatitis C in pregnancy-updated guidelines

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.

A large cohort study shows that buprenorphine treatment during pregnancy significantly lowers the risk of preterm birth, severe maternal morbidity, and neonatal complications in women with opioid use disorder.

Contemporary OB/GYN Senior Editor Angie DeRosa gets insight on the current state of COVID-19 from Christina Han, MD, division director of maternal-fetal medicine at the University of California, Los Angeles, and member of its COVID-19 task force. Han is an active member of the Society for Maternal-Fetal Medicine and discusses the issues on behalf of SMFM.

A new study shows the Stanford Obstetric Recovery Checklist is a valid, reliable, and responsive tool for assessing outpatient postpartum recovery at multiple stages.

Despite abortion bans in several states, a new study showed no significant shift in where OBGYNs choose to practice.